Gregory Van Stavern

ORCID: 0000-0003-0289-9956
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Diseases and Behçet’s Syndrome
  • Cerebral Venous Sinus Thrombosis
  • Retinal and Optic Conditions
  • Peripheral Neuropathies and Disorders
  • Ophthalmology and Eye Disorders
  • Glaucoma and retinal disorders
  • Meningioma and schwannoma management
  • Retinal Imaging and Analysis
  • Migraine and Headache Studies
  • Multiple Sclerosis Research Studies
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Neurosurgical Procedures and Complications
  • Ocular Oncology and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Vasculitis and related conditions
  • Alcoholism and Thiamine Deficiency
  • Retinal Diseases and Treatments
  • Employment and Welfare Studies
  • IgG4-Related and Inflammatory Diseases
  • Child Abuse and Related Trauma
  • Cerebrovascular and genetic disorders
  • Ophthalmology and Visual Health Research
  • Retinopathy of Prematurity Studies
  • Facial Trauma and Fracture Management
  • Autoimmune Neurological Disorders and Treatments

Washington University in St. Louis
2013-2024

Mayo Clinic
2020

University of Minnesota
2020

Prevent Blindness
2019

Scripps Clinic
2019

Wayne State University
2003-2008

Kresge Eye Institute
2004-2008

Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal treatment for reducing relapses is unknown. To help determine the efficacy of long-term immunotherapy in preventing relapse patients MOGAD, we conducted a multicenter retrospective study to rate on various treatments.

10.1212/wnl.0000000000009758 article EN Neurology 2020-06-18
Kathleen B. Digre Bonnie Bruce Michael McDermott Kristin Galetta Laura J. Balcer and 95 more Michael Wall Michael Wall James J. Corbett Steven E. Feldon Deborah I. Friedman John Keltner Karl Kieburtz Mark J. Kupersmith Michael McDermott Eleanor Schron David M. Katz Tippi Hales Cindy Casaceli Rudrani Banik Sanjay Kedhar Flora Levin Jonathan Feistmann Katy Tai Alex Yang Karen M. Tobias Melissa Rivas Lorena Dominguez Violete Perez Reid Longmuir Matthew J. Thurtell Trina Eden Randy H. Kardon Robert L. Lesser Yanina O’Neil Sue Heaton Nathalie Gintowt Danielle S. Rudich Kathleen B. Digre Judith E. A. Warner Barbara Hart Kimberley Wegner Bonnie Carlstrom Susan Allman Bradley J. Katz Anne Haroldsen Byron L. Lam Joshua Pasol Potyra R. Rosa Alexis Morante Jennifer Verriotto David M. Katz T. Asbury Robert D. Gerwin Mary Barnett Steven R. Hamilton Caryl Tongco Beena Gangadharan Eugene F. May Anil D. Patel Bradley K. Farris R. Michael Siatkowsk Heather Miller Vanessa Bergman Kammerin White Steven O’Dell Joseph A. Andrezik Timothy L. Tytle Kenneth S. Shindler Joan DuPont Rebecca Salvo Sheri Drossner Susan Ward Jonathan Lo Stephanie B. Engelhard Elizabeth A. M. Windsor Sami Khella Madhura A. Tamhankar Gregory Van Stavern Jamie Kambarian Renee Van Stavern Karen Civitelli James Shepherd Bonnie Bruce Valérie Biousse Nancy J. Newman Judy Brower Linda Curtis Michael S. Vaphiades Karen Searcey Lanning B. Kline Roy P. McDonald Syndee Givre Tippi Hales Penni Bye Keisha Fuller Kenneth M. Carnes Kimberly James Marisol Ragland Sophia M. Chung Dawn Govreau

The study purpose was to examine vision-specific and overall health-related quality of life (QOL) at baseline in Idiopathic Intracranial Hypertension Treatment Trial patients who were newly diagnosed had mild visual loss. We also sought determine the associations between QOL scores symptoms, function, pain, headache-related disability, obesity.

10.1212/wnl.0000000000001687 article EN Neurology 2015-05-21
Michael Wall Julie Falardeau William A. Fletcher Robert Granadier Byron L. Lam and 95 more Reid Longmuir Anil D. Patel Bonnie Bruce Hua He Michael McDermott Rudrani Banik Sanjay Kedhar Flora Levin Jonathan Feistmann Katy Tai Alex Yang Karen M. Tobias Melissa Rivas Lorena Dominguez Violete Perez Reid Longmuir Matthew J. Thurtell Trina Eden Randy H. Kardon Robert L. Lesser Yanina O’Neil Sue Heaton Nathalie Gintowt Danielle S. Rudich Kathleen B. Digre Judith E. A. Warner Barbara Hart Kimberley Wegner Bonnie Carlstrom Susan Allman Bradley J. Katz Anne Haroldsen Byron L. Lam Joshua Pasol Potyra R. Rosa Alexis Morante Jennifer Verriotto David M. Katz T. Asbury Robert D. Gerwin Mary Barnett Steven R. Hamilton Caryl Tongco Beena Gangadharan Eugene F. May Anil D. Patel Bradley K. Farris R. Michael Siatkowsk Heather Miller Vanessa Bergman Kammerin White Steven O’Dell Joseph A. Andrezik Timothy L. Tytle Kenneth S. Shindler Joan DuPont Rebecca Salvo Sheri Drossner Susan Ward Jonathan Lo Stephanie B. Engelhard Elizabeth A. M. Windsor Sami Khella Madhura A. Tamhankar Gregory Van Stavern Jamie Kambarian Renee Van Stavern Karen Civitelli James Shepherd Bonnie Bruce Valérie Biousse Nancy J. Newman Judy Brower Linda Curtis Michael S. Vaphiades Karen Searcey Lanning B. Kline Roy P. McDonald Syndee Givre Tippi Hales Penni Bye Keisha Fuller Kenneth M. Carnes Kimberly James Marisol Ragland Sophia M. Chung Dawn Govreau John T. Lind Zoë Williams George W. O'Gara Kari Steinmetz Mare Perevich Karen Skrine Elisabeth Carter Rajeev S. Ramchandran

<h3>Objectives:</h3> Determine potential risk factors for progressive visual field loss in the Idiopathic Intracranial Hypertension Treatment Trial, a randomized placebo-controlled trial of acetazolamide patients with idiopathic intracranial hypertension and mild concurrently receiving low sodium, weight reduction diet. <h3>Methods:</h3> Logistic regression classification tree analyses were used to evaluate protocol-defined treatment failure (&gt;2 dB perimetric mean deviation [PMD] change...

10.1212/wnl.0000000000001896 article EN Neurology 2015-08-06

Patients with severe visual loss because of optic neuritis refractory to high dose corticosteroids have limited therapeutic options. The use intravenous immunoglobulin (IVIG) has been advocated in the past, but data are scarce. In this study, we a protocol different from those used other studies, timing and dosage.Consecutive patients corticosteroid-refractive neuropathy were treated IVIG compared control who received only an open-label, non-randomized, controlled prospective...

10.1111/j.1468-1331.2008.02258.x article EN European Journal of Neurology 2008-08-22

Objective: To compare serum B-cell activating factor (BAFF) levels in patients with myasthenia gravis (MG) those control subjects without MG.Design: Case-control study.Subjects: Forty-three MG were compared MG.These included 48 healthy subjects, 25 multiple sclerosis, and 3 amyotrophic lateral sclerosis.Results: In all studied, there was no correlation between the BAFF level concentration of total IgG, IgA, or IgM.The sclerosis not significantly different from subjects.However, higher than...

10.1001/archneur.65.10.1358 article EN Archives of Neurology 2008-10-01

Abstract Importance Identifying risk factors for radiation‐induced optic neuropathy (RION) could promote a more conservative approach to radiation treatment planning in vulnerable patients. Background This study explored possible beyond dose associated with the development of RION after external beam therapy. Design was retrospective case–control conducted at university hospital tertiary care center. Participants Cases ( n = 14) meeting criteria diagnosis by neuro‐ophthalmologic exam were...

10.1111/ceo.12927 article EN Clinical and Experimental Ophthalmology 2017-02-09

Optic disc edema is a feature of many ophthalmic and neurologic conditions. It remains an underappreciated birdshot chorioretinitis (BSCR), leading to delay in diagnosis treatment. The purpose our study was identify clinical features that are concomitant with optic suggest BSCR.

10.1097/wno.0000000000002085 article EN cc-by-nc-nd Journal of Neuro-Ophthalmology 2024-01-25

Optic perineuritis can be a manifestation of infectious and systemic inflammatory disorders, but the majority cases are idiopathic. Myelin oligodendrocyte glycoprotein (MOG)-IgG-positive optic neuritis has been reported to associated with nerve sheath enhancement. This report describes two MOG-IgG patients clinical, radiological therapeutic response consistent perineuritis. may account for many previously described idiopathic Vision loss enhancement on MRI should prompt testing MOG-IgG.

10.1080/01658107.2019.1607883 article EN Neuro-Ophthalmology 2019-05-28

<h3>BACKGROUND AND PURPOSE:</h3> Changes at the optic nerve head on DWI in presence of papilledema have not been systematically studied. The purpose this study was to evaluate if hyperintensity ON heads is associated with papilledema. <h3>MATERIALS METHODS:</h3> In retrospective study, 19 patients (4 men, 15 women; median age, 32 years) and 20 control participants (7 13 48 who had undergone prior MR imaging brain were identified. Two neuroradiologists blinded diagnosis independently reviewed...

10.3174/ajnr.a3388 article EN cc-by American Journal of Neuroradiology 2013-01-31

Introduction We propose a minimum data set framework for the acquisition and analysis of retinal images development Alzheimer's disease (AD) biomarkers. Our goal is to describe methodology that will increase concordance across laboratories, so broader research community able cross-validate findings in parallel, accumulate large databases with normative cognitive aging spectrum, progress application this technology from discovery stage validation search sensitive specific biomarkers AD....

10.1002/dad2.12119 article EN cc-by-nc Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2020-01-01

At times, there is a clinical need for using routine brain MR imaging performed close to the time of onset patients' visual symptoms firmly establish diagnosis optic neuritis. Our aim was assess diagnostic performance radiologists in detecting neuritis on images and whether this could be enhanced postprocessing algorithm.In retrospective case-control study 60 patients (37 women, 23 men; mean age, 47.2 [SD, 17.9] years), 2 blinded neuroradiologists evaluated T2-weighted FLAIR...

10.3174/ajnr.a7068 article EN cc-by American Journal of Neuroradiology 2021-03-18

Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Ophthalmology HomeNew OnlineCurrent IssueFor Authors Podcast Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...

10.1001/jamaophthalmol.2014.5084 article EN JAMA Ophthalmology 2015-03-01

Objectives.—To determine the relationship between levels of ouabain‐like compounds (OLC) in cerebrospinal fluid (CSF) and occurence idiopathic intracranial hypertension (IIH). Background.—OLC are naturally occurring inhibitors sodium‐potassium ATPase that found CSF mammals. Since production is dependent upon activity, since there evidence increased pressure condition IIH may be result production, we hypothesized level endogenous OLC would reduced patients with IIH. Methods.—CSF samples were...

10.1111/j.1526-4610.2006.00527.x article EN Headache The Journal of Head and Face Pain 2006-07-12

A 15-week pregnant 21-year-old woman initially presented with nausea, vomiting, and abdominal pain. The patient admitted to decreased oral intake over the past 4 weeks, including her prescribed prenatal vitamins. She was hypokalemic elevated transaminases gallstone pancreatitis confirmed by imaging. Prior cholecystectomy, fetal heart tones were lost intrauterine demise occurred. underwent dilation evacuation as well cholecystectomy. discharged home but returned within 1 week persistent...

10.1212/wnl.0000000000001178 article EN Neurology 2015-01-27

Idiopathic Intracranial Hypertension (IIH) is a condition in which patients have elevated intracranial pressure does not an apparent cause. To diagnose IIH, evaluation excluding other causes of must be performed. This typically includes magnetic resonance imaging (MRI) the brain and venous sinuses. Despite there being known radiographic signs suggestive IIH on MRI, currently are no established correlations between findings visual outcomes. Previous work revealed diffusion weighted (DWI),...

10.1080/01658107.2024.2337162 article EN Neuro-Ophthalmology 2024-04-19

To describe two patients with anti-HMGCR antibodies, who developed limb-girdle and bulbar weakness, ophthalmoparesis.

10.1212/wnl.0000000000205413 article EN Neurology 2024-04-09

To increase awareness of an uncommon diagnosis by detailing the clinical and radiographic characteristics isolated trochlear nerve schwannomas (TNS).

10.1212/wnl.0000000000205370 article EN Neurology 2024-04-09

Introduction: As the population ages, increasing prevalence of neurodegenerative diseases will have profound implications for health care system. Recognizing visual symptoms from can be challenging, especially in presence co-existing eye diseases. Methods: A seven-question survey was completed by attendees at "neurodegenerative neuro-ophthalmology" symposium during 2017 North American Neuro-ophthalmology Society annual meeting using a web-based audience response Content included...

10.3389/fneur.2020.00679 article EN cc-by Frontiers in Neurology 2020-07-31

Ahealthywoman in her 50s presented to the emergency departmentwith a severe headache for 2 days. Head computed tomography findings were negative and following day, subsided. Soon thereafter, she was noted bemore forgetful unsteady. She seen by an otolaryngologist left-sided hearing loss diagnosed as having Meniere disease. Symptoms mildly abated with meclizine hydrochloride brief course of steroids. After treatment, continued decline neurologically. Subsequently, brain magnetic resonance...

10.1001/jamaophthalmol.2014.631 article EN JAMA Ophthalmology 2014-07-01
Coming Soon ...